The estimated Net Worth of William A Linton is at least 2.31 百万$ dollars as of 5 December 2023. William Linton owns over 10,000 units of Bruker Corp stock worth over 2,114,742$ and over the last 21 years he sold BRKR stock worth over 0$. In addition, he makes 198,012$ as Lead Independent Director at Bruker Corp.
Sign up
William Linton BRKR stock SEC Form 4 insiders trading
William has made over 12 trades of the Bruker Corp stock since 2008, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of BRKR stock worth 190,700$ on 5 December 2023.
The largest trade he's ever made was buying 25,000 units of Bruker Corp stock on 4 November 2008 worth over 134,000$. On average, William trades about 2,811 units every 167 days since 2003. As of 5 December 2023 he still owns at least 33,048 units of Bruker Corp stock.
You can see the complete history of William Linton stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Linton biography
Dr. William A. Linton serves as Lead Independent Director of the Company. Since 1978, Dr. Linton has served as the Chairman, President and Chief Executive Officer of Promega Corporation in Madison, Wisconsin, a privately-held life science supply company founded by Dr. Linton. Dr. Linton received a Bachelor of Science degree from University of California, Berkeley in 1970 and honorary doctorate degrees from Hannam University (Korea) in 2004 and the University of Wisconsin Madison in 2015. Dr. Linton is a director of Analytical, Life Science & Diagnostics Association (an industry association formerly known as Analytical & Life Sciences Systems Associations) ("ALDA"), a director of Heffter Research Institute (a non-profit research institute), a member of the Supervisory Board of Eppendorf AG, Hamburg (a private life sciences company), founder and Executive Director of Usona Institute (a non-profit medical research organization) and President of the BioPharmaceutical Technology Center Institute (a non-profit organization).
What is the salary of William Linton?
As the Lead Independent Director of Bruker Corp, the total compensation of William Linton at Bruker Corp is 198,012$. There are 15 executives at Bruker Corp getting paid more, with Frank Laukien having the highest compensation of 4,909,640$.
How old is William Linton?
William Linton is 72, he's been the Lead Independent Director of Bruker Corp since 2004. There are 1 older and 21 younger executives at Bruker Corp. The oldest executive at Bruker Corp is Marc Kastner, 74, who is the Independent Director.
What's William Linton's mailing address?
William's mailing address filed with the SEC is 2800 Woods Hollow Rd, Fitchburg, WI 53711, USA.
Insiders trading at Bruker Corp
Over the last 21 years, insiders at Bruker Corp have traded over 527,877,336$ worth of Bruker Corp stock and bought 5,273,190 units worth 50,472,973$ . The most active insiders traders include Joerg C Laukien、Isolde Laukien、Marc M Laukien. On average, Bruker Corp executives and independent directors trade stock every 36 days with the average trade being worth of 16,426,809$. The most recent stock trade was executed by Bob Rosenthal on 15 August 2024, trading 12,500 units of BRKR stock currently worth 292,125$.
What does Bruker Corp do?
right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www
What does Bruker Corp's logo look like?
Complete history of William Linton stock trades at Bruker Corp
Bruker Corp executives and stock owners
Bruker Corp executives and other stock owners filed with the SEC include:
-
Frank Laukien,
Chairman of the Board, President, Chief Executive Officer -
Mark Munch,
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division -
Juergen Srega,
President of Bruker CALID Group and Bruker Daltonics Division -
Gerald Herman,
Chief Financial Officer -
Dr. Frank H. Laukien Ph.D.,
Chairman, CEO & Pres -
Burkhard Prause,
President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc -
Falko Busse,
President, Bruker BioSpin Group -
Dr. Mark R. Munch Ph.D.,
Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division -
Juergen Srega,
Pres of Bruker CALID Group & Bruker Daltonics Division -
Gerald N. Herman,
Exec. VP, CFO, Corp. Controller & Interim Head of IR -
Dr. Falko Busse Ph.D.,
Pres of Bruker BioSpin Group -
John Ornell,
Independent Director -
Richard Packer,
Independent Director -
Robert Rosenthal,
Independent Director -
Adelene Perkins,
Independent Director -
William Linton,
Lead Independent Director -
Marc Kastner,
Independent Director -
Hermann Requardt,
Independent Director -
Cynthia Friend,
Independent Director -
Miroslava Minkova,
Director, Investor Relations & Corporate Development -
Bonnie Anderson,
Independent Director -
J. Brent Alldredge J.D.,
Gen. Counsel -
Justin Joseph Ward,
Sr. Director of Investor Relations & Corp. Devel. -
Kristin S. Caplice,
Sec. -
Dr. Burkhard Prause,
Pres and CEO of Bruker Energy & Supercon Technologies, Inc. -
Urban Faeh,
Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH -
Stacey Desrochers,
Treasurer & Director of Investor Relations -
Collin J. D'Silva,
Pres of Chemical Analysis Division -
M Christopher Canavan,
Director -
Richard Kniss,
Director -
Ingen Chris Van,
Director -
Stephen W. Fesik,
Director -
Rene Lenggenhager,
President, BioSpin Group -
Anthony L Mattacchione,
Sr VP, Corp Fin & Accounting -
Gilles Gerard Jean Martin,
Director -
Joerg C Laukien,
10% owner -
Michael Gunnar Knell,
Chief Accounting Officer -
Brenda J Furlong,
Director -
Wolf Dieter Emmerich,
Director -
Taylor Crouch,
Director -
Bob Rosenthal,
-
Laura Francis,
Chief Financial Officer -
John Hulburt,
Dir. of Audit /SEC Compliance -
Martin Haase,
Senior Vice President -
Thomas Werner Bachmann,
President Bruker BioSpin Group -
Charles F Jr Wagner,
Director -
Bernhard Wangler,
Director -
Bernd Gewiese,
President, Bruker BioSpin Corp -
Werner Maas,
President, Bruker BioSpin Corp -
Tony Werner Keller,
Director -
Brian P Monahan,
Corporate Controller -
Dirk D Laukien,
10% owner -
Marc M Laukien,
10% owner -
William J Knight,
Chief Financial Officer -
Richard M Stein,
Secretary -
Isolde Laukien,
10% owner -
Collin J Dsilva,
Director -
Philip Ma,